Showing results (291-300 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|October 15, 2017
Effect of iodine supplementation in pregnant women on child neurodevelopment: a randomised, double-blind, placebo-controlled trialSueppong Gowachirapant, Nidhi Jaiswal, Alida Melse-Boonstra, et al.
The Lancet. Diabetes & Endocrinology|December 4, 2018
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trialHakim-Moulay Dehbi, Ujjal Mallick, Jonathan Wadsley, et al.
The Lancet. Diabetes & Endocrinology|December 24, 2018
New pharmacological strategies for protecting kidney function in type 2 diabetesMarcel H A Muskiet, David C Wheeler, Hiddo J L Heerspink
The Lancet. Diabetes & Endocrinology|December 19, 2018
Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trialMichael P Whyte, Jill H Simmons, Scott Moseley, et al.
The Lancet. Diabetes & Endocrinology|November 22, 2019
Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trialSimon J Griffin, Guy E H M Rutten, Kamlesh Khunti, et al.
The Lancet. Diabetes & Endocrinology|December 25, 2017
Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trialMichael Edmonds, José Luis Lázaro-Martínez, Jesus Manuel Alfayate-García, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2019
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studiesJosef Coresh, Hiddo J L Heerspink, Yingying Sang, et al.
The Lancet. Diabetes & Endocrinology|January 13, 2019
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trialsHiddo J L Heerspink, Tom Greene, Hocine Tighiouart, et al.
The Lancet. Diabetes & Endocrinology|February 25, 2018
Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?Petter Bjornstad, Kim C Donaghue, David M Maahs
The Lancet. Diabetes & Endocrinology|March 4, 2018
Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014Mohammed K Ali, Kai McKeever Bullard, Sharon Saydah, et al.
Pageof 93